Fresenius SE & Co KGaA (FRE) Given a €83.00 Price Target at Deutsche Bank

Fresenius SE & Co KGaA (FRA:FRE) has been given a €83.00 ($98.81) target price by analysts at Deutsche Bank in a report released on Monday. The brokerage currently has a “buy” rating on the stock. Deutsche Bank’s target price indicates a potential upside of 23.95% from the company’s current price.

Other equities research analysts have also recently issued research reports about the stock. Berenberg Bank set a €89.10 ($106.07) price objective on shares of Fresenius SE & Co KGaA and gave the stock a “buy” rating in a research note on Wednesday, October 25th. Oddo Bhf set a €82.00 ($97.62) price objective on shares of Fresenius SE & Co KGaA and gave the stock a “buy” rating in a research note on Monday, October 23rd. Citigroup set a €83.00 ($98.81) price objective on shares of Fresenius SE & Co KGaA and gave the stock a “buy” rating in a research note on Thursday, October 19th. Morgan Stanley set a €83.00 ($98.81) price target on shares of Fresenius SE & Co KGaA and gave the company a “buy” rating in a research note on Wednesday, October 4th. Finally, Independent Research set a €86.00 ($102.38) price target on shares of Fresenius SE & Co KGaA and gave the company a “buy” rating in a research note on Thursday, November 2nd. One investment analyst has rated the stock with a sell rating, five have given a hold rating and eleven have given a buy rating to the stock. Fresenius SE & Co KGaA has an average rating of “Buy” and an average price target of €78.66 ($93.65).

Fresenius SE & Co KGaA (FRA FRE) opened at €66.96 ($79.71) on Monday. The stock has a market cap of $37,070.00 and a PE ratio of 21.32. Fresenius SE & Co KGaA has a 1-year low of €60.16 ($71.62) and a 1-year high of €80.00 ($95.24).

COPYRIGHT VIOLATION NOTICE: This piece was posted by American Banking News and is the sole property of of American Banking News. If you are viewing this piece on another domain, it was stolen and reposted in violation of international trademark & copyright laws. The correct version of this piece can be viewed at https://www.americanbankingnews.com/2018/01/22/fresenius-se-83-00-price-target-at-deutsche-bank.html.

Fresenius SE & Co KGaA Company Profile

Fresenius SE & Co KGaA, a health care group, provides products and services for dialysis, hospitals, and outpatient medical care worldwide. The company operates through Fresenius Medical Care, Fresenius Kabi, Fresenius Helios, and Fresenius Vamed segments. The Fresenius Medical Care segment offers products for patients with chronic kidney failure.

Analyst Recommendations for Fresenius SE & Co KGaA (FRA:FRE)

Receive News & Ratings for Fresenius SE & Co KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fresenius SE & Co KGaA and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply